1-pentanoyl-N-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl} -pyrrolidine-2-carboxamide: Investigation of structural variations

Archiv der Pharmazie

Volumn 344, Issue 9, 2011, Pages 617-626

  Catalano, Alessia ^a   Carocci, Alessia ^a   Di Mola, Antonia ^a   Bruno, Claudio ^a   Vanderheyden, Patrick M L ^b   Franchini, Carlo ^a  

^a UNIVERSITY OF BARI   (Italy)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

AT 1 receptors; binding affinity; sartans; tetrazoles

Indexed keywords

1 PENTANOYL N[[2' (1H TETRAZOL 5 YL)BIPHENYL 4 YL]METHYL]PYRROLIDINE 2 CARBOXAMIDE; ANGIOTENSIN 1 RECEPTOR; TETRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ACIDITY; AMINO ACID COMPOSITION; ANIMAL CELL; ARTICLE; BINDING AFFINITY; BIOLOGICAL ACTIVITY; FEMALE; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; BIPHENYL COMPOUNDS; CHO CELLS; CRICETINAE; HUMANS; LIGANDS; LOSARTAN; MOLECULAR STRUCTURE; PROTEIN BINDING; PYRROLIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; TETRAZOLES;

EID: 80052414491     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.201000296     Document Type: Article

References (20)

1. M. B. Vallotton, Trends Pharmacol. Sci. 1987, 8, 69-74.
2. M. J. Robertson, Angiotensin antagonists, in Receptor-based drug design (Ed.:, P. Leff,), Marcel Decker, New York 1998, pp. 207-209.
3. P. B. M. W. M. Timmermans, P. Benfiend, A. T. Chiu, W. F. Herblin, P. C. Wong, Am. J. Hypertens. 1992, 5, 221S-235S.
4. J. C. Hodges, J. M. Hamby, C. J. Blankey, Drug Future 1992, 17, 575-593.
5. M. Burnier, H. R. Brunner, Kidney Intern. 1998, 54 (Suppl 68), S1107-S1111.
6. N. A. Awan, D. T. Mason, Am. Heart J. 1996, 131, 177-185.
7. R. R. Wexler, W. J. Greenlee, J. D. Irvin, M. R. Goldberg, K. Prendergast, R. D. Smith, P. B. M. W. M. Timmermans, J. Med. Chem. 1996, 39, 625-656.
8. C. Lamanna, A. Catalano, A. Carocci, A. Di Mola, F. Franchini, V. Tortorella, M. S. Sinicropi, P. M. L. Vanderheyden, K. A. Watson, S. Sciabola, ChemMedChem 2007, 2, 1298-1310.
9. K. Noda, Y. Saad, A. Kinoshita, T. P. Boyle, R. M. Graham, A. Husain, S. S. Karnik, J. Biol. Chem. 1995, 270, 2284-2289.
10. W. T. Ashton, C. L. Cantone, L. L. Chang, J. Med. Chem. 1993, 36, 591-609.
11. P. Bovy, D. B. Reitz, J. T. Collins, T. S. Chamberlain, G. M. Olins, V. M. Corpus, E. G. MacMahon, M. A. Palomo, J. P. Koepke, G. J. Smits, D. E. MacGraw, J. F. Gaw, J. Med. Chem. 1993, 36, 101-110.
12. W. V. Murray, M. P. Wachter, U.S. Patent 791939, 1991; Chem. Abstr. 1993, 26, 5182288.
13. R. H. Bradbury, C. P. Allott, M. Dennis, E. Fisher, J. S. Major, B. B. Masek, A. A. Oldham, R. J. Rearce, N. Rankine, J. M. Revill, D. A. Roberts, S. T. Russell, J. Med. Chem. 1992, 35, 4027-4038.
14. P. M. L. Vanderheyden, F. Fierens, J. P. De Backer, N. Freyman, G. Vauquelin, Br. J. Pharmacol. 1999, 126, 1057-1065.
15. F. L. P. Fierens, P. M. L. Vanderheyden, Z. Gaborik, T. L. Minh, J. P. De Backer, L. Hunyady, A. Yzerman, G. Vauquelin, J. Renin-Angiotensin Syst. 2000, 1, 283-288.
16. A. Carocci, G. Lentini, A. Catalano, M. M. Cavalluzzi, C. Bruno, M. Muraglia, N. A. Colabufo, N. Galeotti, F. Corbo, R. Matucci, C. Ghelardini, C. Franchini, ChemMedChem 2010, 5, 696-704.
17. D. J. Carini, J. V. Duncia, A. L. Johnson, A. T. Chiu, W. A. Price, P. C. Wong, P. B. M. W. M. Timmermans, J. Med. Chem. 1990, 33, 1330-1336.
18. W. C. Still, M. Kahn, A. Mitra, J. Org. Chem. 1978, 43, 2923-2925.
19. J. V. Duncia, A. T. Chiu, D. J. Carini, G. B. Gregory, A. L. Johnson, W. A. Price, G. J. Wells, R. R. Wexler, P. C. Wong, J. C. Calabrese, P. B. M. W. M. Timmermans, J. Med. Chem. 1990, 33, 1312-1329.
20. I. Verheijen, F. L. P. Fierens, J. P. DeBacker, G. Vauquelin, P. M. L. Vanderheyden, Fundam. Clin. Pharmacol. 2000, 14, 577-585.